Erythrocytosis and Primary Aldosteronism

Abstract
Erythrocytosis as an unusual complication of cancer has been documented in an increasing number of reports. The prevalence and the pathogenesis of this association have recently been reviewed by Lange and Pavlovic-Kentera (1). In selected instances an apparent direct causal relationship between uterine myoma, cerebellar hemangioblastoma, renal carcinoma, renal adenoma, or pheochromocytoma and erythrocytosis has been suggested because of remission of the erythrocytosis after surgical extirpation or radiologic obliteration of the tumor. Moreover, elevation of plasma erythropoietin levels has been described in patients with erythrocytosis and renal carcinoma (2), hepatic carcinoma (2-4), cerebellar hemangioblastoma (5, 6), or pheochromocytoma (7), and